Citations (21)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Amir Reza Abedi, Saleh Ghiasy, Morteza Fallah-karkan, Amirhossein Rahavian & Farzad Allameh. (2020) The Management of Patients Diagnosed with Incidental Prostate Cancer: Narrative Review. Research and Reports in Urology 12, pages 105-109.
Read now
Read now
Jan Adolfsson, Hans Garmo, Eberhard Varenhorst, Göran Ahlgren, Christer Ahlstrand, Ove Andrén, Anna Bill-Axelson, Ola Bratt, Jan-Erik Damber, Karin Hellström, Magnus Hellström, Erik Holmberg, Lars Holmberg, Jonas Hugosson, Jan-Erik Johansson, Bill Petterson, Magnus Törnblom, Anders Widmark & Pär Stattin. (2007) Clinical characteristics and primary treatment of prostate cancer in Sweden between 1996 and 2005. Scandinavian Journal of Urology and Nephrology 41:6, pages 456-477.
Read now
Read now
Articles from other publishers (19)
Jang Hee Han, Dae Hyuk Chung, Min Chul Cho, Ja Hyeon Ku, Chang Wook Jeong, Cheol Kwak, Jae-Seung Paick & Seung-June Oh. (2023) Natural history of incidentally diagnosed prostate cancer after holmium laser enucleation of the prostate. PLOS ONE 18:2, pages e0278931.
Crossref
Crossref
Zhenlang Guo, Junwei He, Lijuan Huang, Zhaohui Wang, Ping Hu, Shusheng Wang, Zunguang Bai & Jun Pan. (2022) Prevalence and risk factors of incidental prostate cancer in certain surgeries for benign prostatic hyperplasia: A systematic review and meta-analysis. International braz j urol 48:6, pages 915-929.
Crossref
Crossref
Clément Klein, Thibault Marquette, Grégoire Capon, Mokrane Yacoub, Eric Alezra, Jean-Christophe Bernhard, Franck Bladou & Grégoire Robert. (2022) Incidental prostate cancer after holmium laser enucleation of the prostate: incidence and predictive factors for clinical progression. International Journal of Clinical Oncology 27:6, pages 1077-1083.
Crossref
Crossref
Stefano Luzzago, Mattia Luca Piccinelli, Giulia Marvaso, Ekaterina Laukhtina, Noriyoshi Miura, Victor M. Schuettfort, Keiichiro Mori, Abdulmajeed Aydh, Matteo Ferro, Francesco A. Mistretta, Nicola Fusco, Giuseppe Petralia, Barbara A. Jereczek-Fossa, Shahrokh F. Shariat, Pierre I. Karakiewicz, Ottavio de Cobelli & Gennaro Musi. (2021) Active surveillance for prostate cancer: comparison between incidental tumors vs. tumors diagnosed at prostate biopsies. World Journal of Urology 40:2, pages 443-451.
Crossref
Crossref
Chris Bangma & Monique Roobol. (2017) Real-time Watchful Surveillance Looks Like Active Waiting. European Urology 72:6, pages 908-909.
Crossref
Crossref
Jan Herden, Sebastian Wille & Lothar Weissbach. (2016) Active surveillance in localized prostate cancer: comparison of incidental tumours (T1a/b) and tumours diagnosed by core needle biopsy (T1c/T2a): results from the HAROW study. BJU International 118:2, pages 258-263.
Crossref
Crossref
Jerome Gnanaraj, Shobana Balakrishnan, Zarish Umar, Emmanuel S. Antonarakis, Christian P. Pavlovich, Scott M. Wright & Waseem Khaliq. (2016) Medical hospitalizations in prostate cancer survivors. Medical Oncology 33:7.
Crossref
Crossref
Rami Klaff, Johan Rosell, Eberhard Varenhorst & Gabriel Sandblom. (2016) The Long-term Disease-specific Mortality of Low-risk Localized Prostate Cancer: A Prospective Population-based Register Study Over Two Decades. Urology 91, pages 77-82.
Crossref
Crossref
Priya Bhosale, Aparna Balachandran, Raghu Vikram, Chitra Viswanathan, Homer Macapinlac, Eric Rohren & Ramanujan Prativadi. (2013) What Is the Clinical Significance of FDG Unexpected Uptake in the Prostate in Patients Undergoing PET/CT for Other Malignancies?. International Journal of Molecular Imaging 2013, pages 1-6.
Crossref
Crossref
V. Misraï, M. Rouprêt, J. Guillotreau, B. Bordier & F. Bruyère. (2013) Traitement de l’hyperplasie bénigne de prostate par photovaporisation au laser Greenlight® : analyse de la littérature. Progrès en Urologie 23:2, pages 77-87.
Crossref
Crossref
Jung Kwon Kim, Sung Yong Cho, Chang Wook Jeong, Seung Bae Lee, Ja Hyeon Ku, Sung Kyu Hong, Seok-Soo Byun, Cheol Kwak, Hyeon Hoe Him, Sang Eun Lee & Hyeon Jeong. (2012) Patients aged more than 70 had higher risk of locally advanced prostate cancers and biochemical recurrence in Korea. BJU International 110:4, pages 505-509.
Crossref
Crossref
Changhee YooCheol Young OhSe Joong KimSun Il KimYoung Sig KimJong Yeon ParkDo Hwan SeongYun Seob SongWon Jae YangHyun Chul ChungIn Rae ChoSung Yong ChoSang Hyeon CheonSungjoon HongJin Seon Cho. (2012) Preoperative Clinical Factors for Diagnosis of Incidental Prostate Cancer in the Era of Tissue-Ablative Surgery for Benign Prostatic Hyperplasia: A Korean Multi-Center Review. Korean Journal of Urology 53:6, pages 391.
Crossref
Crossref
Susan Voigt, Friederike Hüttig, Rainer Koch, Stefan Propping, Catharina Propping, Marc‐Oliver Grimm & Manfred Wirth. (2011) Risk factors for incidental prostate cancer—who should not undergo vaporization of the prostate for benign prostate hyperplasia?. The Prostate 71:12, pages 1325-1331.
Crossref
Crossref
Brian T. Helfand, Anne K. Mongiu, Donghui Kan, Dae-Yun Kim, Stacy Loeb, Kimberly A. Roehl, Joshua J. Meeks, Norm D. Smith & William J. Catalona. (2009) Outcomes of radical prostatectomy for patients with clinical stage T1a and T1b disease. BJU International 104:3, pages 304-309.
Crossref
Crossref
O Andrèn, H Garmo, L Mucci, S-O Andersson, J-E Johansson & K Fall. (2008) Incidence and mortality of incidental prostate cancer: a Swedish register-based study. British Journal of Cancer 100:1, pages 170-173.
Crossref
Crossref
Jan Adolfsson. (2008) The Management of Category T1a–T1b (Incidental) Prostate Cancer: Can We Predict Who Needs Treatment?. European Urology 54:1, pages 16-18.
Crossref
Crossref
Umberto Capitanio, Vincenzo Scattoni, Massimo Freschi, Alberto Briganti, Andrea Salonia, Andrea Gallina, Renzo Colombo, Pierre I. Karakiewicz, Patrizio Rigatti & Francesco Montorsi. (2008) Radical Prostatectomy for Incidental (Stage T1a–T1b) Prostate Cancer: Analysis of Predictors for Residual Disease and Biochemical Recurrence. European Urology 54:1, pages 118-125.
Crossref
Crossref
Steven Joniau. (2008) Editorial Comment on: Predictive Factors for Progression in Patients with Clinical Stage T1a Prostate Cancer in the PSA Era. European Urology 53:2, pages 362.
Crossref
Crossref
Mounir Lefi, Wadia Hellara, Mounir Touffahi, Nassim Fredj, Moussa Adnene, Radhia Saidi & Hamadi Saad. (2007) Cancer de prostate : étude comparative stade T1a et stade T1b. Progrès en Urologie 17:7, pages 1343-1346.
Crossref
Crossref